| Literature DB >> 35448879 |
Shucong Lin1, Isaac Oyediran2, Ying Niu1, Sebe Brown3, Don Cook4, Xinzhi Ni5, Yan Zhang2, Francis P F Reay-Jones6, Jeng Shong Chen2, Zhimou Wen2, Marcelo Dimase1, Fangneng Huang1.
Abstract
The corn earworm/bollworm, Helicoverpa zea (Boddie), is a pest species that is targeted by both Bacillus thuringiensis (Bt) maize and cotton in the United States. Cry1Ab and Vip3Aa20 are two common Bt toxins that are expressed in transgenic maize. The objective of this study was to determine the resistance allele frequency (RAF) to Cry1Ab and Vip3Aa20 in H. zea populations that were collected during 2018 and 2019 from four southeastern U.S. states: Louisiana, Mississippi, Georgia, and South Carolina. By using a group-mating approach, 104 F2 iso-lines of H. zea were established from field collections with most iso-lines (85) from Louisiana. These F2 iso-lines were screened for resistance alleles to Cry1Ab and Vip3Aa20, respectively. There was no correlation in larval survivorship between Cry1Ab and Vip3Aa20 when the iso-lines were exposed to these two toxins. RAF to Cry1Ab maize was high (0.256) and the RAFs were similar between Louisiana and the other three states and between the two sampling years. In contrast, no functional major resistance allele (RA) that allowed resistant insects to survive on Vip3Aa20 maize was detected and the expected RAF of major RAs with 95% probability was estimated to 0 to 0.0073. However, functional minor RAs to Vip3Aa20 maize were not uncommon; the estimated RAF for minor alleles was 0.028. The results provide further evidence that field resistance to Cry1Ab maize in H. zea has widely occurred, while major RAs to Vip3Aa20 maize are uncommon in the southeastern U.S. region. Information that was generated from this study should be useful in resistance monitoring and refinement of resistance management strategies to preserve Vip3A susceptibility in H. zea.Entities:
Keywords: Bt maize; Cry1Ab; F2 screen; Helicoverpa zea; Vip3A; resistance allele frequencies
Mesh:
Substances:
Year: 2022 PMID: 35448879 PMCID: PMC9028807 DOI: 10.3390/toxins14040270
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 5.075
Larval survival of H. zea iso-lines that were collected in Louisiana and other states in F2 screen for detecting Cry1Ab and Vip3Aa20 resistance alleles a.
| Year | State | F2 Screen Against Cry1Ab | F2 Screen Against Vip3Aa20 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total No. Lines Screened | Total Neonates Screened | Total No. Lines Survived | Total No. Larvae Survived | No. Lines Having ≥3rd Instars | No. ≥3rd Instars | Total No. Lines Screened | Total Neonates Screened | Total No. Lines Survived | Total No. Larvae Survived | No. Lines Having ≥3rd Instars | No. ≥3rd Instars | ||
| 2018 | Louisiana | 32 | 4096 | 31 | 1448 | 26 | 571 | 33 | 4224 | 24 | 182 | 6 | 34 |
| Other states | 18 | 2304 | 18 | 691 | 16 | 334 | 19 | 2432 | 9 | 41 | 1 | 6 | |
| Sub-total (2018) | 50 | 6400 | 49 | 2139 | 42 | 905 | 52 | 6656 | 33 | 223 | 7 | 40 | |
| 2019 | Louisiana | 47 | 5415 | 46 | 1677 | 45 | 1299 | 49 | 5492 | 6 | 33 | 3 | 12 |
| Total | 97 | 11,815 | 95 | 3816 | 87 | 2204 | 101 | 12,148 | 39 | 256 | 10 | 52 | |
a Number of F2 neonates per iso-line that were screened against Cry1Ab was 60–96 for each of 13 iso-lines that were collected in 2019 and against Vip3Aa20 was 64–84 for each of 9 iso-lines that were collected during 2019. For all other iso-lines, the number of F2 neonates that were screened per iso-line was 128 for each Bt toxin.
Susceptibility of the offspring of H. zea survivors in the F2 screen against Cry1Ab and Vip3Aa20 toxins.
| Strains | No. Neonates Assayed | Slope ± SE | LC50 (95%CI, or Larval Mortality at the Highest Concentrations Assayed) | χ2 | Resistance Ratio * | |
|---|---|---|---|---|---|---|
| Cry1Ab | ||||||
| SS-BZ (assayed in 2018) | 617 | 1.41 ± 0.17 | 0.29 (0.21, 0.42) | 132.4 | <0.0001 | |
| PPL-Cry1Ab-2018-I | 445 | >31.6 (33.3%) | >109 | |||
| PPL-Cry1Ab-2018-II | 367 | 0.75 ± 0.15 | 3.31(1.99, 6.81) | 11.3 | 0.6620 | 11 |
| PPL-Cry1Ab-2018-III | 402 | 1.45 ± 0.19 | 8.6 1(6.34, 12.4) | 18.19 | 0.1099 | 30 |
| SS-BZ (assayed in 2019) | 448 | 2.10 ± 0.28 | 0.14 (0.11, 0.19) | 22.72 | 0.0648 | |
| PPL-Cry1Ab-2019 | 576 | 1.15 ± 0.16 | 13.76(9.68, 21.88) | 19.13 | 0.1600 | 98 |
| Vip3Aa20 | ||||||
| SS-BZ (assayed in 2018) | 1190 | 2.39 ± 0.56 | 0.36 (0.22, 0.52) | 78.4 | <0.0001 | |
| PPL-Vip3Aa20-2018-I | 375 | 1.74 ± 0.28 | 3.96(2.20, 9.51) | 6.51 | 0.0893 | 11 |
| PPL-Vip3Aa20-2018-II | 352 | 1.60 ± 0.30 | 2.51(1.54, 4.30) | 37.61 | 0.0006 | 7 |
| SS-BZ (assayed in 2019) | 512 | 2.64 ± 0.44 | 0.47 (0.33–0.67) | 39.96 | 0.0007 | |
| PPL-Vip3Aa20-2019 | 576 | 1.67 ± 0.16 | 1.89 (1.46, 2.41) | 16.51 | 0.5567 | 4 |
* Resistance ratio was calculated based on the LC50 of a strain that was derived from the F2 survivors divided by the LC50 of the known susceptibility strain, SS-BZ, assayed in the same year.
Expected genotype frequencies in the F2 populations and the expected number of live larvae in the F2 screen against Cry1Ab.
| Parent Genotype | Expected Genotype Frequency (f) in F2 Populations a | Expected Number of Survivors in the F2 Screen b | ||
|---|---|---|---|---|
| fSS | fRS | fRR | ||
| SSSS | 1 | 0 | 0 | 0 |
| RSSS | 0.5625 | 0.375 | 0.0625 | 34.9 |
| RRSS/RSRS | 0.25 | 0.5 | 0.25 | 66.5 |
| RRRS | 0.0625 | 0.375 | 0.5625 | 94.9 |
| RRRR | 0 | 0 | 1 | 120 |
a fSS, fRS, and fRR represent the expected SS, RS, and RR genotype frequencies, respectively, in the F2 progeny of an iso-line. b The expected number of survivors was calculated based on 128 neonates that were screened per iso-line.
Estimated resistance allele frequencies to Cry1Ab and Vip3Aa20 in H. zea populations that were collected from Louisiana and three other southeastern states of the United States.
| Bt Toxin | Year | State | Total Iso-Lines Screened | No Resistance Alleles in a Mated Parent Female | Expected Resistance Allele Frequency (95% CI) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | Total | |||||
| Functional major resistant alleles | ||||||||||
| Cry1Ab | 2018 | Louisiana | 32 | 6 | 24 | 2 | 0 | 0 | 28 | 0.223 (0.156, 0.298) |
| 2018 | Other states | 18 | 2 | 16 | 0 | 0 | 0 | 16 | 0.230 (0.142, 0.331) | |
| Sub-total 2018 | 50 | 8 | 40 | 2 | 0 | 0 | 44 | 0.223 (0.168, 0.283) | ||
| 2019 | Louisiana | 47 | 2 | 37 | 6 | 2 | 0 | 55 | 0.295 (0.232, 0.361) | |
| Total | All states | 97 | 10 | 77 | 8 | 2 | 0 | 99 | 0.256 (0.214, 0.301) | |
| Vip3A | 2018 | Louisiana | 33 | 33 | 0 | 0 | 0 | 0 | 0 | 0 to 0.0218 |
| 2018 | Other states | 19 | 19 | 0 | 0 | 0 | 0 | 0 | 0 to 0.0368 | |
| Sub-total 2018 | 52 | 52 | 0 | 0 | 0 | 0 | 0 | 0 to 0.0140 | ||
| 2019 | Louisiana | 49 | 49 | 0 | 0 | 0 | 0 | 0 | 0 to 0.0149 | |
| Total | All state | 101 | 101 | 0 | 0 | 0 | 0 | 0 | 0 to 0.0073 | |
| Vip3A | Functional minor resistance alleles | |||||||||
| 2018 | Louisiana | 33 | 27 | 6 | 0 | 0 | 0 | 6 | 0.054 (0.023, 0.100) | |
| 2018 | Other states | 19 | 18 | 1 | 0 | 0 | 0 | 1 | 0.025 (0.003,0.069) | |
| Sub-total 2018 | 52 | 45 | 7 | 0 | 0 | 0 | 7 | 0.039 (0.017, 0.070) | ||
| 2019 | Louisiana | 49 | 46 | 3 | 0 | 0 | 0 | 3 | 0.020 (0.006, 0.044) | |
| Total | All states | 101 | 91 | 10 | 0 | 0 | 0 | 10 | 0.028 (0.014, 0.047) | |